EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Combination of CT/MRI LI-RADS With Second-Line Contrast-Enhanced Ultrasound Using Sulfur Hexafluoride or Perfluorobutane for Diagnosing Hepatocellular Carcinoma in High-Risk Patients

Yu Li iD, Sheng Li iD, Qing Li iD, Kai Li iD, Jing Han iD, Siyue Mao iD, Xiaohong Xu iD, Zhongzhen Su iD, Yanling Zuo iD, Shousong Xie iD, Hong Wen iD, Xuebin Zou iD und 3 weitere

Korean Journal of Radiology · 2025

DOI: 10.3348/kjr.2024.0980 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Korean Journal of Radiology, 2025. Verfasst von Yu Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Contrast Media, Magnetic Resonance Imaging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NNSFC, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The CT/MRI Liver Imaging Reporting and Data System (LI-RADS) demonstrates high specificity with relatively limited sensitivity for diagnosing hepatocellular carcinoma (HCC) in high-risk patients. This study aimed to explore the possibility of improving sensitivity by combining CT/MRI LI-RADS v2018 with second-line contrast-enhanced ultrasound (CEUS) LI-RADS v2017 using sulfur hexafluoride (SHF) or perfluorobutane (PFB). MATERIALS AND METHODS: This retrospective analysis of prospectively collected multicenter data included high-risk patients with treatment-naive hepatic observations. The reference standard was pathological confirmation or a composite reference standard (only for benign lesions). Each participant underwent concurrent CT/MRI, SHF-enhanced US, and PFB-enhanced US examinations. The diagnostic performances for HCC of CT/MRI LI-RADS alone and three combination strategies (combining CT/MRI LI-RADS with either LI-RADS SHF, LI-RADS PFB, or a modified algorithm incorporating the Kupffer-phase findings for PFB [modified PFB]) were evaluated. For the three combination strategies, apart from the CT/MRI LR-5 criteria, HCC was diagnosed if CT/MRI LR-3 or LR-4 observations met the LR-5 criteria using LI-RADS SHF, LI-RADS PFB, or modified PFB. RESULTS: In total, 281 participants (237 males; mean age, 55 ± 11 years) with 306 observations (227 HCCs, 40 non-HCC malignancies, and 39 benign lesions) were included. Using LI-RADS SHF, LI-RADS PFB, and modified PFB, 20, 23, and 31 CT/MRI LR-3/4 observations, respectively, were reclassified as LR-5, and all were pathologically confirmed as HCCs. Compared to CT/MRI LI-RADS alone (74%, 95% confidence interval [CI]: 68%-79%), the three combination strategies combining CT/MRI LI-RADS with either LI-RADS SHF, LI-RADS PFB, or modified PFB increased sensitivity (83% [95% CI: 77%-87%], 84% [95% CI: 79%-89%], 88% [95% CI: 83%-92%], respectively; all P < 0.001), while maintaining the specificity at 92% (95% CI: 84%-97%). CONCLUSION: The combination of CT/MRI LI-RADS with second-line CEUS using SHF or PFB improved the sensitivity of HCC diagnosis without compromising specificity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsContrast MediaMagnetic Resonance ImagingSulfur HexafluorideTomography, X-Ray ComputedHumansMaleFemaleMiddle AgedUltrasonographyRetrospective StudiesFluorocarbonsAgedSensitivity and SpecificityAdultMultimodal Imaging

Stichwörter der Autor:innen

Computed tomographyContrast-enhanced ultrasoundHepatocellular carcinomaJoint diagnosisLiver imaging reporting and data systemMagnet resonance imaging

Substanzen

Contrast MediaSulfur HexafluorideFluorocarbonsperfluorobutane

Autor:innen und Institutionen

  • Department of Ultrasound, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Can…
  • Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Canc…
  • Department of Ultrasound, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Department of Ultrasound, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
  • Department of Ultrasound, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
  • Department of Ultrasound Imaging, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.

ORCID-Profile: Yu Li, Sheng Li, Qing Li, Kai Li, Jing Han, Siyue Mao, Xiaohong Xu, Zhongzhen Su, Yanling Zuo, Shousong Xie, Hong Wen, Xuebin Zou, Jingxian Shen, Lingling Li, Jianhua Zhou

Förderung

  • NNSFC
  • National Natural Science Foundation of China

Zitieren

APA

Li, Y., Li, S., Li, Q., Li, K., Han, J., Mao, S., Xu, X., Su, Z., Zuo, Y., Xie, S., Wen, H., Zou, X., Shen, J., Li, L., & Zhou, J. (2025). Combination of CT/MRI LI-RADS With Second-Line Contrast-Enhanced Ultrasound Using Sulfur Hexafluoride or Perfluorobutane for Diagnosing Hepatocellular Carcinoma in High-Risk Patients. Korean Journal of Radiology. https://doi.org/10.3348/kjr.2024.0980

Vancouver

Li Y, Li S, Li Q, Li K, Han J, Mao S, et al. Combination of CT/MRI LI-RADS With Second-Line Contrast-Enhanced Ultrasound Using Sulfur Hexafluoride or Perfluorobutane for Diagnosing Hepatocellular Carcinoma in High-Risk Patients. Korean Journal of Radiology. 2025. doi:10.3348/kjr.2024.0980

BibTeX
@article{Li2025,
  author = {Li, Yu and Li, Sheng and Li, Qing and Li, Kai and Han, Jing and Mao, Siyue and Xu, Xiaohong and Su, Zhongzhen and Zuo, Yanling and Xie, Shousong and Wen, Hong and Zou, Xuebin and Shen, Jingxian and Li, Lingling and Zhou, Jianhua},
  title = {Combination of CT/MRI LI-RADS With Second-Line Contrast-Enhanced Ultrasound Using Sulfur Hexafluoride or Perfluorobutane for Diagnosing Hepatocellular Carcinoma in High-Risk Patients},
  journal = {Korean Journal of Radiology},
  year = {2025},
  doi = {10.3348/kjr.2024.0980}
}
Kostenlos starten →